|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.64 USD | -1.61% |
|
-6.50% | +3.66% |
| 05-23 | Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes | MT |
| 05-21 | Haemonetics Insider Sold Shares Worth $254,443, According to a Recent SEC Filing | MT |
Haemonetics Corporation reported earnings results for the fourth quarter ended March 30, 2024. For the fourth quarter, the company reported sales was USD 343.29 million compared to USD 304.42 million a year ago. Net income was USD 20.37 million compared to USD 29.38 million a year ago.
Diluted earnings per share from continuing operations was USD 0.4 compared to USD 0.57 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.66% | 4.51B | |
| -5.31% | 181B | |
| -1.21% | 108B | |
| -5.53% | 66.57B | |
| +1.22% | 49.95B | |
| +7.03% | 43.84B | |
| +4.91% | 41.71B | |
| +21.96% | 31.59B | |
| +14.45% | 25.3B | |
| -6.68% | 23.94B |
HAEMONETICS CORPORATION 
